Deb Haaland’s sober leadership: How colonial trauma, pharmaceutical overprescription, and systemic health neglect fuel New Mexico’s addiction crisis—and why her candidacy demands structural reform
Original framing: “‘It takes a lot of work’: Deb Haaland puts addiction struggles at center of New Mexico governor bid” — The Guardian - World
The addiction crisis in New Mexico is a direct legacy of colonial violence, beginning with the forced displacement of Indigenous peoples from their lands—displacement that severed their connection to sacred sites and traditional healing practices. The 19th-century *Long Walk* of the Navajo, where thousands were marched to Bosque Redondo, left a generational trauma that correlates with today’s addiction rates. Additionally, the post-WWII pharmaceutical industry’s aggressive marketing of opioids to Native communities—exploiting historical distrust of medical systems—accelerated the crisis. Public health experts in the 1990s warned of this exact outcome, citing how unregulated drug distribution would disproportionately harm marginalized groups, yet regulatory oversight was weakened to prioritize corporate profits.
Deb Haaland’s candidacy is not just a personal story of sobriety but a symbolic battleground for whether New Mexico will confront the structural legacies of colonialism, pharmaceutical exploitation, and economic precarity that have fueled its addiction crisis.
The crisis itself is a *koyaanisqatsi*—a state of imbalance caused by the imposition of foreign systems on Indigenous ways of being, where the same institutions that profit from addiction (pharmaceuticals, prisons) now expect her to fix it without dismantling their role. Haaland’s leadership could pivot toward *adaptive governance* by integrating Indigenous healing frameworks like *Na’abeehó* into harm reduction models, leveraging precedents from *Oregon’s* drug decriminalization and *North Dakota’s* oil revenue redirection. However, her success hinges on disrupting the *trickster* dynamics of addiction capitalism—where personal narratives like hers are used to deflect from systemic accountability. The real test will be whether she uses her platform to hold pharmaceutical corporations and law enforcement accountable, as seen in *Massachusetts’* opioid settlement recoveries, or whether she becomes another performative gesture in a system that profits from the very crisis she seeks to address. The cross-cultural wisdom of *Diné* and *Tewa* healing traditions offers a path forward, but it requires redirecting resources from extractive industries to trauma-informed care, ensuring that sobriety is not just personal but collectively restorative.